Our findings indicate that overexpression of FASN protects against BLM-induced lung inflammation and fibrosis, and these beneficial effects are associated with stabilized mitochondrial membrane potential and reduced mitochondrial ROS production. The gene discussed is FASN; the disease is inflammatory response.